The Judicial Circuit Court for the City of St. Louis granted preliminary approval of Bayer’s (BAYRY) Roundup $7.25B class-action settlement, according to Bloomberg.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BAYRY:
- Bayer gets FDA clearance of Medrad MRXperion Magnetic Resonance Injection System
- Bayer reports Q4 core EPS EUR 0.62 vs. EUR 1.05 last year
- Bayer sees FY26 sales EUR 45B-EUR 47B
- Bayer’s Real-World Colorectal Cancer Data Could Quietly Support BAYRY
- The Week That Was, The Week Ahead: Macro and Markets, Mar. 1